Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) Antibodies:
anti-Mouse (Murine) Antibodies:
Go to our pre-filtered search.
Dog (Canine) Polyclonal MAP1LC3A Primary Antibody for ELISA, FACS - ABIN250719
Zhang, Yu, Pan, Hu, Hao, Cai, Zhu, Yu, Xie, Ma, Yuan: Small molecule regulators of autophagy identified by an image-based high-throughput screen. in Proceedings of the National Academy of Sciences of the United States of America 2007
Show all 201 Pubmed References
Human Polyclonal MAP1LC3A Primary Antibody for ICC, IF - ABIN388483
Sivridis, Koukourakis, Zois, Ledaki, Ferguson, Harris, Gatter, Giatromanolaki: LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. in The American journal of pathology 2010
Show all 31 Pubmed References
Cow (Bovine) Polyclonal MAP1LC3A Primary Antibody for FACS, ICC - ABIN446593
Dehay, Bové, Rodríguez-Muela, Perier, Recasens, Boya, Vila: Pathogenic lysosomal depletion in Parkinson's disease. in The Journal of neuroscience : the official journal of the Society for Neuroscience 2010
Show all 16 Pubmed References
Dog (Canine) Polyclonal MAP1LC3A Primary Antibody for ELISA, ICC - ABIN250720
Kabeya, Mizushima, Ueno, Yamamoto, Kirisako, Noda, Kominami, Ohsumi, Yoshimori: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. in The EMBO journal 2000
Show all 6 Pubmed References
Human Polyclonal MAP1LC3A Primary Antibody for DB - ABIN1881524
Scherz-Shouval, Weidberg, Gonen, Wilder, Elazar, Oren: p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. in Proceedings of the National Academy of Sciences of the United States of America 2010
Show all 5 Pubmed References
Dog (Canine) Polyclonal MAP1LC3A Primary Antibody for ELISA, IHC (fro) - ABIN250721
Mizushima, Yamamoto, Hatano, Kobayashi, Kabeya, Suzuki, Tokuhisa, Ohsumi, Yoshimori: Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. in The Journal of cell biology 2001
Show all 5 Pubmed References
Human Polyclonal MAP1LC3A Primary Antibody for IF (p), IHC (p) - ABIN1714263
Chen, Wei, Nie, Lin, Tian, Liu, Yu, Cheng, Yan, Wang, Liu, Deng, Lai, Zhou, Zhang, Lin, Chen: ?-Asarone prevents autophagy and synaptic loss by reducing ROCK expression in asenescence-accelerated prone 8 mice. in Brain research 2014
Show all 2 Pubmed References
Human Polyclonal MAP1LC3A Primary Antibody for DB, EIA - ABIN1449623
Su, Chao, Huang, Weng, Jeng, Lai: Rab5 and class III phosphoinositide 3-kinase Vps34 are involved in hepatitis C virus NS4B-induced autophagy. in Journal of virology 2011
Show all 9 Pubmed References
Cow (Bovine) Polyclonal MAP1LC3A Primary Antibody for FACS - ABIN4330444
Kohler, Reed, Sarraf, Arteaga, Newton, Roy: Effector Protein Cig2 Decreases Host Tolerance of Infection by Directing Constitutive Fusion of Autophagosomes with the Coxiella-Containing Vacuole. in mBio 2016
Cow (Bovine) Polyclonal MAP1LC3A Primary Antibody for IHC, WB - ABIN2784522
Taylor, Kirkegaard: Modification of cellular autophagy protein LC3 by poliovirus. in Journal of virology 2007
Co-expression of FKBP8 (show FKBP8 Antibodies) with LC3A profoundly induces Parkin (show PARK2 Antibodies)-independent mitophagy. Strikingly, even when acting as a mitophagy receptor, FKBP8 (show FKBP8 Antibodies) avoids degradation by escaping from mitochondria. In summary, this study identifies novel roles for FKBP8 (show FKBP8 Antibodies) and LC3A, which act together to induce mitophagy.
we report that autophagy is associated with apoptosis processes, involving LC3 and TRIF (show TRIM69 Antibodies)-colocation in human HCC (show FAM126A Antibodies) cells. Regulation of autophagy and the TLR3 (show TLR3 Antibodies)-TRIF (show TRIM69 Antibodies) pathway may be effective in the treatment of liver cancer.
The autophagy induced by 2-PCPA requires LC3-II processing machinery..2-PCPA treatment induces the change of global gene expression program, including a series of autophagy-related genes, such as SQSTM1/p62 (show SQSTM1 Antibodies). Taken together, our data indicate that KDM1A/LSD1 (show KDM1A Antibodies) inhibitors induce autophagy through affecting the expression of autophagy-related genes and in a BECN1 (show BECN1 Antibodies)-independent manner
LC3 and p62/SQSTM1 (show SQSTM1 Antibodies) have roles in early-stage non-small cell lung cancer
Hotspot mutations in the arginine-rich stretch in MAP1LC3A resulting in reduced cleavage of MAP1LC3A by ATG4B (show ATG4B Antibodies) both in vitro and in vivo, suggesting a functional implication of this gene mutation in cancer development.
FYCO1 (show FYCO1 Antibodies) and MAP1LC3A interact through a novel binding mode that involves Atg8 (show GABARAPL2 Antibodies)-family proteins
analysis of soluble SQSTM1 (show SQSTM1 Antibodies) complexes and soluble complexes formed between SQSTM1 (show SQSTM1 Antibodies) oligomers and LC3 using a combination of fluorescence microscopy-based biophysical approaches in living cells
we found that ATG14 interacted with Ulk1 and LC3, and knock down of Ulk1 prevented the lipidation of LC3 and autophagy in HeLa-ATG14 cells. We also identified a phosphatidylethanolamine (PE) binding region in ATG14, and the addition of Ulk1 to Hela-ATG14 cells decreased the ATG14-PE interaction.
Legionella pneumophila RavZ extracts LC3-PE from the membrane before deconjugation. RavZ initially recognizes the LC3 molecule on membranes via its N-terminal LC3-interacting region (LIR (show CD300C Antibodies)) motif.
The results are consistent with a model in which RPIA (show RPIA Antibodies) suppresses autophagy and LC3 processing by modulation of redox signaling.
the conjugation of ubiquitin-like LC3 homologs to the phospholipids of membranes may change the destiny of the membranes beyond degradation through lysosomal fusion
paxillin (show PXN Antibodies) interacts with processed LC3 through a conserved LIR (show CD300C Antibodies) motif in the amino-terminal end of paxillin (show PXN Antibodies) and that this interaction is regulated by oncogenic SRC (show SRC Antibodies) activity.
These results suggest that the Golgi complex may serve as a membrane platform for noncanonical autophagy where V-ATPase (show ATP6V1H Antibodies) is (show ATP11A Antibodies) a key player.
LC3 was down regulated in the hypothalamus of diabetic mice.
LC3 overexpression in 3T3-L1 preadipocytes stimulates adipocyte differentiation via direct modulation of RKIP (show PEBP1 Antibodies)-dependent ERK1 (show MAPK3 Antibodies) activity.
Development of LC3/GABARAP (show GABARAP Antibodies) sensors containing a LIR (show CD300C Antibodies) and a hydrophobic domain to monitor autophagy.
These findings demonstrate that LC3 contributes to melanogenesis by increasing ERK (show EPHB2 Antibodies)-dependent MITF (show MITF Antibodies) expression, thereby providing a mechanistic insight into the signaling network that links autophagy to melanogenesis.
LC3 is exploited by coxsackievirus in both autophagy-dependent and -independent manners in vivo
LC3 overexpression thus exerts neuroprotection through increasing alpha7nAChR expression for eAbeta binding and further enhancing autophagic activity for Abeta (show APP Antibodies) clearance in vitro and in vivo.
Hedgehog (show SHH Antibodies) signaling is required for the Lc3 synthase (show B3GNT5 Antibodies) expression in embryonic lens
LC3 is localized in porcine oocytes during in vitro maturation.
Data suggest that expression of MAP1LC3A in graafian follicle/granulosa cell/theca cell is distinct in normal pigs versus miniature pigs; expression of MAP1LC3A is higher in normal pigs than in miniature pigs; MAP1LC3A may be marker of autophagy.
Data indicate that the expression of MAP1LC3A, B and autophagy-associated genes (ATG5 (show ATG5 Antibodies), mTOR (show FRAP1 Antibodies), Beclin-1 (show BECN1 Antibodies)) was increased in normal pigs, while decreased in miniature pigs.
MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. The protein encoded by this gene is one of the light chain subunits and can associate with either MAP1A or MAP1B. Two transcript variants encoding different isoforms have been found for this gene. The expression of variant 1 is suppressed in many tumor cell lines, suggesting that may be involved in carcinogenesis.
microtubule-associated protein 1 light chain 3 alpha
, 35-alpha calcimedin
, Annexin III (Lipocortin III)
, lipocortin III
, placental anticoagulant protein III
, MAP1 light chain 3-like protein 1
, MAP1A/1B light chain 3 A
, MAP1A/MAP1B LC3 A
, MAP1A/MAP1B light chain 3 A
, autophagy-related ubiquitin-like modifier LC3 A
, microtubule-associated proteins 1A/1B light chain 3
, microtubule-associated proteins 1A/1B light chain 3A
, autophagy-related protein LC3 A
, microtubule-associated protein 1-light chain 3A
, microtubule-associated proteins 1A/1B light chain 3B
, UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5A
, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5
, beta-1,3-N-acetylglucosaminyltransferase 5A
, lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase A
, lactotriaosylceramide synthase A
, lc(3)Cer synthase A
, lc3 synthase A